estriol has been researched along with Bladder, Overactive in 3 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the efficacy of antimuscarinics alone versus antimuscarinics in combination with local oestrogens for OAB; to verify whether risk factors for lower antimuscarinic efficacy can be overcome by the concomitant use of local oestrogens." | 2.74 | Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity? ( Bolis, P; Cardozo, L; Salvatore, S; Serati, M; Uccella, S, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matarazzo, MG | 1 |
Caruso, S | 1 |
Giunta, G | 1 |
Valenti, G | 1 |
Sarpietro, G | 1 |
Cianci, A | 1 |
Serati, M | 1 |
Salvatore, S | 1 |
Uccella, S | 1 |
Cardozo, L | 1 |
Bolis, P | 1 |
Wenderlein, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Is There A Synergic Effect Of Topical Oestrogens When Associated To Antimuscarinics In The Treatment Of Symptomatic Detrusor Overactivity[NCT00648310] | Phase 2/Phase 3 | 0 participants | Interventional | 2004-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for estriol and Bladder, Overactive
Article | Year |
---|---|
Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Drug Synergi | 2009 |
2 other studies available for estriol and Bladder, Overactive
Article | Year |
---|---|
Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
Topics: Aged; Aged, 80 and over; Drug Administration Schedule; Estriol; Estrogens; Female; Female Urogenital | 2018 |
Local estriol treatment.
Topics: Administration, Intravaginal; Estriol; Female; Humans; Prospective Studies; Treatment Outcome; Ureth | 2010 |